| ||||||||||||||
|
|
|||||||||||||

*Department of Anesthesiology and
Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida
Address correspondence and reprint requests to Roy G. Soto, MD, 12901 Bruce B. Downs Blvd., MDC 59, Department of Anesthesiology, College of Medicine, University of South Florida, Tampa, FL 33612. Address e-mail to rsoto{at}hsc.usf.edu
| Abstract |
|---|
|
|
|---|
IMPLICATIONS: Capnography is not a mandatory monitor for monitored anesthesia care procedures, nor is it required for sedation performed outside of the operating room, although there are practice guidelines that suggest that monitoring of ventilatory function be used to reduce the risk of adverse outcomes. Use of capnography can enhance detection of apnea during sedation procedures and potentially improve patient safety.
| Introduction |
|---|
|
|
|---|
The purpose of this study was to determine whether capnography accurately detects apnea during sedation. Because clinicians routinely use different oxygen flow rates during procedural sedation, a secondary goal was to determine whether oxygen flow rate affected the ability of the capnograph to detect apnea.
| Methods |
|---|
|
|
|---|
Patients were excluded from study participation if they were pregnant, aged <18 yr, or could not maintain a SpO2 of >88% on room air. Dropout criteria included the need to place an artificial airway to maintain ventilation or the need to institute artificial ventilation.
A cannula designed to administer nasal oxygen and sample both nasal and oral carbon dioxide (Smart CapnoLineTMO2 O2/CO2 Oral Nasal Cannula; Oridion, Jerusalem, Israel) was appropriately positioned to measure PETCO2 with a handheld capnometer (NPB-70; Nellcor, Pleasanton, CA; sampling rate, 50 mL/min via both the oral and nasal ports). We chose this cannula because of availability, and a recent abstract has shown that when this oral/nasal cannula is compared with the standard nasal cannula, there is no benefit in CO2 detection (9). The capnogram was calibrated with a 5% CO2 gas container. Transthoracic impedance monitoring (970S; Respironics, Pittsburgh, PA) was used as the control for respiratory rate monitoring on all patients, and lead placement was standardized as recommended by the manufacturer.
Before the administration of IV drugs, the accuracy of the transthoracic impedance-derived respiratory rate was verified by timed coincident visual inspection of chest motion associated with breathing for 1 min. A five-lead electrocardiogram and SpO2 monitoring were displayed continuously for all patients. Noninvasive arterial blood pressure was measured every 2.5 min. Sedation and analgesia were administered at the discretion of the anesthesia care providers (anesthesia residents and nurse anesthetists supervised by faculty anesthesiologists at a large teaching institution), who were blinded to the capnography and transthoracic impedance data. The oxygen flow rate through the nasal cannula was randomized to 0, 2, 4, and 6 L/min for 3 min at each flow rate. Every 12 min, the randomized sequence of oxygen trials was repeated throughout the study.
Data were collected at baseline and at the end of each 3-min trial, unless otherwise triggered by apnea for >20 s or SpO2 <88%. Values for SpO2 and PETCO2 were collected during the last minute of each 3-min trial and averaged. Apnea or airway obstruction for 20 s, detected by using transthoracic impedance monitoring, triggered notification of the anesthesia care provider if the apnea was undetected by routine monitoring. Twenty seconds was specifically chosen because of safety concerns of the IRB.
Categorical data are presented as raw values, percentages, or incidences. Continuous data are summarized as mean ± SD. Continuous data were compared by using a two-factor (time and oxygen flow rate) analysis of variance. When the F ratio was significant at the 0.05 level, Tukeys honestly significant difference post hoc test was used to distinguish differences in means. Logistic regression analysis was used to examine simultaneously whether apnea was predicted by age, sex, weight, smoking history, alcohol ingestion, sleep apnea, chronic obstructive pulmonary disease, sedative, analgesic, procedure, and/or duration of sedation.
| Results |
|---|
|
|
|---|
|
| Discussion |
|---|
|
|
|---|
The American Society of Anesthesiologists Standards for Basic Anesthesia Monitoring state that "During regional anesthesia and monitored anesthesia care, the adequacy of ventilation shall be evaluated, at least, by continual observation of qualitative clinical signs." Although continuous capnography is required for all patients undergoing general anesthesia, it is optional for MAC/sedation cases. The need for CO2 monitoring has been studied by other medical specialties that frequently use procedural sedation, including gastroenterology (11), dentistry (12,13), and emergency medicine (1416), and many specialties now recommend capnography as a standard monitoring device. No studies have compared the incidence of apnea/obstruction detection with capnography versus impedance plethysmography, nor have the effects of oxygen flow rate on capnographic detection of apnea been evaluated.
In this study, 26% of our patients undergoing MAC with sedation/analgesia experienced apnea of at least 20 seconds. None of the patients experienced hemodynamic changes. None of the episodes was detected by the anesthesia providers, and our study did not analyze how long the apnea would have continued without intervention. Reasons for the lack of detection are unclear, but one could argue that 20 seconds is a short, possibly inconsequential episode, especially in patients breathing supplemental oxygen. During apnea, the reduction in SpO2 is moderated by the reserve of oxygen in gas-exchanging alveoli. For example, Farmery and Roe (17) reported that while patients breathed room air, apnea resulted in SpO2
85% within 60 seconds.
The implications of this study are that episodes of apnea for at least 20 seconds are frequent during MAC and these episodes can go undetected by anesthesia care providers. Left undetected, this persistent hypoventilation could lead to progressive hypercarbia and acidosis, which may be significant by the time the SpO2 monitor alarms in a patient receiving supplemental oxygen. Apnea can be readily and easily detected by using nasal capnography, which has the advantage of detecting airway obstruction with chest wall movement, versus chest wall plethysmography. Although supplemental oxygen delivery affects the amplitude of the capnograph, detection of apnea is unchanged.
Limitations of this study, as previously mentioned, include the 20 second limit on apnea. One could argue that allowing for a longer apnea time may end in spontaneous resolution or that such a short period is not clinically relevant, as evidenced by the lack of hemodynamic instability. However, longer apnea might result in more significant arterial oxygen desaturation and hypercapnia, placing the patient at an unnecessary and unacceptable risk. The ethics of performing a study until safety is compromised are questionable, especially when it is established that apnea and airway obstruction are undesirable events during any anesthetic.
Capnography provides both a quantitative and qualitative measure of ventilation, but it provides only an approximation of changes in tidal volume, as noted by the wave form, if gas inflow is constant. As shown in Table 2, increasing oxygen flow rates decreased the amplitude of measured CO2, probably via dilution, making the quantitative value as an assessment of adequacy of ventilation less reliable. All episodes of apnea, however, were still detected accurately regardless of flow rate.
|
The American Society of Anesthesiologists guidelines for sedation by nonanesthesiologists strongly recommend monitoring of ventilation, but they are less emphatic on the use of capnography because of the lack of supporting studies (20). Although we are cautious in our extrapolation of these results to the nonanesthesia provider in an outside location, we believe that our protocol represents a "best-case scenario." As anesthesiologists, our primary goal is to ensure patient safety and comfort. With procedural sedation being an increasingly popular option used by trained anesthesia care providers and nontrained individuals alike, it is imperative that research efforts in procedural sedation be directed toward facilitating the diagnosis of scenarios which can lead to adverse events before they occur.
| Acknowledgments |
|---|
| Footnotes |
|---|
Presented in part at the IARS 77th Clinical & Scientific Congress, March 2125, 2003, New Orleans, LA.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. Vespasiano, M. Finkelstein, and S. Kurachek Propofol Sedation: Intensivists' Experience With 7304 Cases in a Children's Hospital Pediatrics, December 1, 2007; 120(6): e1411 - e1417. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Overdyk, R. Carter, R. R. Maddox, J. Callura, A. E. Herrin, and C. Henriquez Continuous Oximetry/Capnometry Monitoring Reveals Frequent Desaturation and Bradypnea During Patient-Controlled Analgesia Anesth. Analg., August 1, 2007; 105(2): 412 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Lightdale, D. A. Goldmann, H. A. Feldman, A. R. Newburg, J. A. DiNardo, and V. L. Fox Microstream Capnography Improves Patient Monitoring During Moderate Sedation: A Randomized, Controlled Trial Pediatrics, June 1, 2006; 117(6): e1170 - e1178. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Overdyk, R. Carter, and R. Maddox New JCAHO Pain Standard Bigger Threat to Patient Safety Than Envisioned. Anesth. Analg., May 1, 2006; 102(5): 1596 - 1596. [Full Text] [PDF] |
||||
![]() |
Q. A. Fisher Can Capnography Substitute for Auscultation in Sedation Cases? Anesth. Analg., May 1, 2005; 100(5): 1546 - 1546. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|